Page 96 - Uji Klinik Fase III Vaksin COVID-19 di Indonesia

Judul : 'Merah Putih Vaccine' Currently Developed for COVID-19, Says
Jokowi

Nama Media : tempo.co

Tanggal : 11 Agustus 2020
Halaman/URL: https://en.tempo.co/read/1374656/merah-putih-vaccine-currently-
developed-for-covid-19-says-jokowi

Tipe Media : Media Online

TEMPO.CO, Jakarta - President Joko “Jokowi”
Widodo on Tuesday, August 11, announced
that the government is currently preparing a
locally-produced COVID-19 vaccine. It comes
parallel to the vaccine currently developed by
state-pharmaceutical firm Bio Farma with
China’s Sinovac Biotech.

President Jokowi said the local vaccine has
been given the name “Vaksin Merah Putih” or the red and white vaccine, referring to
Indonesia’s national flag.

“For the past three months, we have developed our own vaccine from the COVID-19
that has spread in Indonesia,” said Jokowi while visiting Bio Farma’s third clinical trial
at Padjadjaran University, West Java.

Moreover, he said that this vaccine is entirely produced domestically by Eijkman
Institute for Molecular Biology, the Agency for the Assessment and Application of
Technology (BPPT), the Indonesian Institute of Sciences (LIPI), The Indonesian Food
and Drug Monitoring Agency (BPOM), the Research and Technology Ministry, along
with a number of Indonesian universities.

“We do wish the Merah Putih vaccine will soon be completed. We forecast its
completion in mid-2021,” said Jokowi.

The announcement confirms that the Indonesian government is developing numerous
vaccine candidates for COVID-19 with countries such as China, South Korea, and the
United Arab Emirates.